BG45

BG45

Catalog Number:
L002371337APE
Mfr. No.:
APE-B5949
Price:
$260
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          Description:IC50: 289 nMHistone deacetylases (HDACs) represent novel molecular targets for the treatment of various types of cancers including multiple myeloma (MM). Many HDAC inhibitors have already shown remarkable anti-tumor activities in the preclinical studies, however, their clinical utility is limited due to unfavorable toxicities associated with their broad range HDAC inhibitory effects. BG45 is a novel small molecule HDAC3-selective inhibitor. In vitro: BG45 is reported as an HDAC class I inhibitor with selectivity for HDAC3 over HDAC1, 2. Consistent with HDAC3 knockdown data, BG45 significantly inhibited MM cell growth dose-dependently. Importantly, BG45 also triggered a potent growth inhibitory effect against patient-derived MM cells, without affecting normal donor PBMCs [1]. In vivo: BG45 significantly inhibited MM tumor growth in a dose-dependent fashion. For example, significant differences were observed in control versus BG45 15 mg/kg, control versus BG45 50 mg/kg, and BG45 15 mg/kg versus BG45 50 mg/kg at day 22. Moreover, BG45 50 mg/kg in combination with bortezomib enhanced either single agent activity further. These results confirmed that BG45 triggers in vivo anti-MM activities [1]. Clinical trial: Up to now, BG45 is still in the preclinical development stage.

      • Properties
        • Alternative Name
          (Z)-N-(2-aminophenyl)pyrazine-2-carbimidic acid
          CAS Number
          926259-99-6
          Molecular Formula
          C11H10N4O
          Molecular Weight
          214.22
          Appearance
          A crystalline solid
          Purity
          98.00%
          Solubility
          Soluble in DMSO
          Storage
          Store at -20°C

          * For Research Use Only

    We Also Recommend

    AZD8186

    $276

    LFM-A13

    $188

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.